VEGFR2 Antikörper (Kinase insert Domain Receptor (A Type III Receptor tyrosine Kinase)) (C-Term)

Details for Product anti-KDR Antibody No. ABIN2385246
Target
Bindungsspezifität
C-Term, AA 1327-1356
40
34
30
20
17
16
15
13
12
12
10
9
8
8
7
7
7
6
6
5
5
5
4
4
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Reaktivität
Human
344
215
132
25
6
4
4
4
4
2
2
2
2
2
2
2
2
2
1
1
1
1
1
Wirt
Kaninchen
323
63
17
2
1
1
1
1
Klonalität
Polyklonal
Konjugat
Dieser VEGFR2 Antikörper ist unkonjugiert
37
21
17
17
13
10
10
8
8
8
8
8
3
3
3
3
3
2
2
2
2
2
1
1
Applikation
Flow Cytometry (FACS), Immunofluorescence (IF), Immunohistochemistry (IHC), ELISA, Western Blotting (WB)
248
167
129
106
74
49
29
26
21
14
13
13
11
7
4
4
2
1
Optionen
Immunogen VEGFR2 (FLK1/KDR) antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1327~1356 amino acids from the C-terminal region of human KDR/FLK1.
Isotyp IgG
Kreuzreaktivität Human
Kreuzreaktivität (Details) Calculated cross reactivity: Hu
Produktmerkmale VEGFR2, CT (KDR, FLK1, KDR, VEGFR2, Vascular endothelial growth factor receptor 2, Fetal liver kinase 1, Kinase insert domain receptor, Protein-tyrosine kinase receptor flk-1)
Reinigung Purified by Protein G affinity chromatography.
Target
Andere Bezeichnung VEGFR2 (KDR Antibody Abstract)
UniProt P35968
Pathways RTK Signalweg, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling
Applikations-hinweise Optimal working conditions should be determined by the investigator.
Beschränkungen Nur für Forschungszwecke einsetzbar
Format Liquid
Buffer Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
Konservierungs-mittel Sodium azide
Vorsichtsmaßnahmen This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung -20 °C
Informationen zur Lagerung -20°C